Approval · Notice of Compliance 14318 · 2013
NU-ACYCLOVIR: Notice of Compliance 14318
Issued April 25, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14318
- Date
- April 25, 2013
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Additional drug substance supplier
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZORIVAX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-ACYCLOVIR | Not yet assigned | — |